T-DXd (trastuzumab deruxtecan)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for T-DXd (trastuzumab deruxtecan), covering 2026-04-16 to 2026-04-16. Get the full timeline:
Most recent: Clinical Trial Update: Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer [Phase 3]